Skip to search formSkip to main contentSkip to account menu

CP 91149

Known as: CP-91149 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2004
2004
Pharmacological inhibition of liver GP (glycogen phosphorylase), which is currently being studied as a treatment for Type II (non… 
2004
2004
The experimental evaluation of the contribution of glycogen phosphorylase (GP) to biochemical pathways is limited to methods that… 
Highly Cited
2003
Highly Cited
2003
Multiple signalling pathways are involved in the mechanism by which insulin stimulates hepatic glycogen synthesis. In this study… 
Highly Cited
2002
Highly Cited
2002
Two distinct allosteric inhibitors of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-D-arabinitol (DAB) and CP-91149 (an indole-2… 
Highly Cited
2001
Highly Cited
2001
We used metabolic control analysis to determine the flux control coefficient of phosphorylase on glycogen synthesis in…